In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A.
In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. Research Abstract Details
A summary is given of the in vivo screening results for selected antitumor antibiotics in various stages of the National Cancer Institute drug development program. In addition a brief description of general screening practices of the program is given. After long-term usage of leukemia L1210 as a primary screen, a new screening panel is being initiated with P388 leukemia as a prescreening system. Illustrative data on anguidine, actinomycin D, macromomycin, aclacinomycin, and other fermentation products are shown.
In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. Publishing Authors By Initials
In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. Journal Published:
PUBLICATION TYPE: Journal Article
Journal: Recent results in cancer research. Fortschritte de
VOLUME: 63
Page Numbers: 49-57
Journal Abbreviation: Recent Results Cancer Res.
ISSN: 0080-0015
DAY: 13
MONTH: 02
YEAR: 1978
In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. Information
Number of References:
LANGUAGE: eng
NlmUniqueID: 44671
In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. Keywords Mesh Terms:
KEYWORDS: United States
MESH TERMS: drug therapy
Chemical & Substance for Abstract: In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A. Information
Substance Name: Antibiotics, Antineoplastic
Registry Number: 0
Grant and Affiliation Information for In vivo antitumor evaluation of antibiotics. Selected results from the Drug Evaluation Program of the National Cancer Institute, U.S.A.
AFFILIATION:
Country: GERMANY, WEST
AGENCY:
GRANT:
ACRONYM:
MEDLINETA: Recent Results Cancer Res
REFSOURCE:
DATABASENAME:
ACCESSION NUMBER:
Number Hits: 0
In vivo antitumor evaluation of antibiotics Selected results from the Drug Evaluation Program of the National Cancer Institute, USA Related Publications